Company: SWKH
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001628280-25-050155
Chunk: 47

Company: SWK Holdings Corp
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 47
---
 (Loss) RecognizedMarketable InvestmentsNumber of SharesFunded AmountGAAP BalanceQ3 2025Year-to-DateAOTI Common Stock (5)402,634 N/A230 (191)(276)Elutia, Inc (8)50,000 N/A$45 $(55)$(38)

29

Privately Held SharesNumber of SharesEpica International, Inc25,000 Sincerus Pharmaceuticals, Inc26,575 MolecuLight, Inc250,000 

Change in Fair Value Warrants to Purchase StockNumber of SharesExercise Price per ShareGAAP BalanceQ3 2025Year-to-Date4Web, Inc. TBD $— $— $— $— ImpediMed Tranche 112,491,870 $0.05 180 29 (131)ImpediMed Tranche 26,245,935 $0.05 90 (88)(88)Aziyo Biologics, Inc. Tranche 1157,895 $6.65 38 (91)(315)Aziyo Biologics, Inc. Tranche 230,075 $6.65 7 (17)(60)Biotricity, Inc. Tranche 19,589 $6.26 — — — Biotricity, Inc. Tranche 2600,000 $0.50 309 92 145 Biotricity, Inc. Tranche 354,300 $2.21 13 (36)(36)Biotricity, Inc Tranche 427,150 $2.21 13 (36)(36)CDMO Manufacturer211,442 $1.42 — — — DxTerity Diagnostics, Inc.2,019,231 $— — — — Epica International, Inc. TBD $— — — — Eton Pharmaceuticals, Inc. Tranche 151,239 $5.86 829 367 405 Eton Pharmaceuticals, Inc. Tranche 218,141 $6.62 288 127 140 Eton Pharmaceuticals, Inc. Tranche 3289,736 $5.32 5,350 2,061 2,342 Nicoya Lifesciences, Inc276,